ADUS

Addus HomeCare Corporation

Healthcare Providers and Services · USD

ADUS

Price

$93.5

+2.09%

Cap

$1.7B

Earnings

4/4 beat

30d Trend

+2%

ADUS
Loading chart data...
0 data pointsPowered by Brain47
52-week range7%
91.14124.91

Near 52-week lows — potential value or falling knife

Analyst consensus (15 analysts)+49% to target
10 Strong Buy2 Buy2 Hold0 Sell1 Strong Sell

Target range: $102$160 (consensus: $139.46)

Consensus: Buy

Earnings history

Q4 2025

BEAT

1.77 vs 1.65

Q3 2025

BEAT

1.56 vs 1.53

Q2 2025

BEAT

1.49 vs 1.46

Q1 2025

BEAT

1.42 vs 1.33

VolatilityModerate

Key macro factors

·

Ongoing Medicaid redeterminations are significantly impacting patient onboarding and retention in key states like Illinois, Texas, and New Mexico, leading to disruptions in census growth for Addus HomeCare.

·

Rising inflation and global economic uncertainties, partly driven by the Middle East conflict and potential IMF downgrades, could increase operational costs for Addus HomeCare's caregivers (e.g., fuel, wages) and potentially influence government healthcare funding upon which the company heavily relies.

·

Labor market dynamics, including a strong US job market with low unemployment, may lead to increased wage pressures for home healthcare caregivers, potentially affecting Addus HomeCare's profit margins if these costs cannot be fully offset by rate increases or efficiencies.

Addus HomeCare Corporation provides a range of home-based care services, including personal care, hospice, and home health, primarily to elderly, chronically ill, and disabled individuals in the United States.

Next earnings:2026-05-04

QUANT SCORE

Building intelligence for this stock. Brain47 needs a few days of price data to calculate technical indicators and generate a full quant score.

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.

Addus HomeCare Corporation (ADUS) — Brain47 AI Score 53/100 | Analysis